CI Investments Inc’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-73,906
| Closed | -$6.66M | – | 1313 |
|
|
2024
Q4 | $6.66M | Sell |
73,906
-1,070,339
| -94% | -$96.4M | 0.03% | 275 |
|
|
2024
Q3 | $113M | Sell |
1,144,245
-93,964
| -8% | -$9.28M | 0.43% | 51 |
|
|
2024
Q2 | $115M | Sell |
1,238,209
-101,231
| -8% | -$9.39M | 0.45% | 45 |
|
|
2024
Q1 | $127M | Buy |
1,339,440
+1,286,041
| +2,408% | +$122M | 0.5% | 39 |
|
|
2023
Q4 | $4.77M | Buy |
53,399
+5,228
| +11% | +$467K | 0.02% | 281 |
|
|
2023
Q3 | $3.52M | Hold |
48,171
| – | – | 0.02% | 288 |
|
|
2023
Q2 | $4.01M | Hold |
48,171
| – | – | 0.02% | 284 |
|
|
2023
Q1 | $3.67M | Hold |
48,171
| – | – | 0.02% | 290 |
|
|
2022
Q4 | $4M | Sell |
48,171
-10,000
| -17% | -$830K | 0.02% | 291 |
|
|
2022
Q3 | $4.61M | Sell |
58,171
-15,000
| -20% | -$1.19M | 0.02% | 290 |
|
|
2022
Q2 | $5.43M | Buy |
73,171
+21,081
| +40% | +$1.57M | 0.03% | 273 |
|
|
2022
Q1 | $4.68M | Buy |
52,090
+51,890
| +25,945% | +$4.66M | 0.02% | 328 |
|
|
2021
Q4 | $22K | Buy |
+200
| New | +$22K | ﹤0.01% | 1072 |
|
|
2019
Q1 | – | Sell |
-414,083
| Closed | -$29.7M | – | 369 |
|
|
2018
Q4 | $29.7M | Sell |
414,083
-136,517
| -25% | -$9.79M | 0.19% | 128 |
|
|
2018
Q3 | $52.8M | Sell |
550,600
-23,000
| -4% | -$2.21M | 0.4% | 77 |
|
|
2018
Q2 | $54.6M | Sell |
573,600
-23,300
| -4% | -$2.22M | 0.43% | 72 |
|
|
2018
Q1 | $52.4M | Buy |
+596,900
| New | +$52.4M | 0.6% | 54 |
|